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Abstract
We report a rare case of Bowel Associated Dermatosis – Arthritis Syndrome in a young patient
with complex Crohn's disease who presented with fever, arthritis, rash and worsening of diarrhea
with abdominal pain, who promptly responded to a short course of steroids.
Case Presentation
A 23 year old white male with a 4 year history of Crohn's
disease presented with an acute two day history of
malaise, fever, abdominal pain, vomiting and stomal diar-
rhoea. He complained of joint pains affecting the shoul-
ders, elbows, wrists, metacarpophalangeals, knees and
ankles. There was also a rash on the elbows, ankles and
feet, which began as erythematous macules and evolved
to vesico-pustular lesions followed by crusting. There was
no history of sexual exposure or any intercurrent infec-
tion. He was on no regular medication, but had discontin-
ued Pentasa 4 months earlier.
One month earlier he had undergone a laparotomy to
excise a complex ileo-cutaneous fistula with blind tracts,
and two weeks earlier a defunctioning ileostomy had been
created in view of persistent abdominal pain. The cutane-
ous fistula had been present for a year, but was associated
with a terminal ileal stricture and ileo-rectal fistula of at
least 2 years duration. His bowel disease had been resist-
ant to immunosuppressive drugs including azathioprine,
corticosteroiods and three infusions of Infliximab a year
earlier. There had been no extra-intestinal manifestations.
On admission to the hospital, he was thin, afebrile with a
resting tachycardia of 125/minute. The rest of the cardio-
respiratory examination was normal. The abdomen was
minimally tender around the ileostomy without guarding
or rebound tenderness. Examination of the skin revealed
some pustules and crusts around the elbows, ankles and
feet (Fig 1 and 2). The buttocks were spared. There were
clinical signs of synovitis of the wrists, proximal inter-
phalangeal and metacarpophalangeal joints, and also
both ankles.
Results of the laboratory tests showed a haemoglobin of
13.1 gm/dl, white blood count 15.8 × 109/L, platelets 585
× 109/L, C- reactive protein 37.7 mg/L and erythrocyte
sedimentation rate 69 mm/hr. Urea and electrolytes, com-
plement, urine analysis and microscopy were normal.
Rheumatoid factor, antinuclear and antineutrophil cyto-
plasmic antibodies, cryoglobulins and Hepatitis B and C
serology were negative. Transthoracic echocardiogram
showed no signs of endocarditis, and multiple blood cul-
tures were sterile. A skin biopsy from the ankle revealed a
perivascular lymphohistiocytic infiltrate with prominent
neutrophils and associated fibrinoid necrosis of vessels
consistent with 'leukocytoclastic' vasculitis.
He was commenced on 60 mg prednisolone per day lead-
ing to prompt and complete resolution of all features. The
dose of prednisolone was rapidly tapered over the course
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of one month by the patient, faster than advised but with-
out any recurrence over the following 3 years.
Discussion
The "bowel bypass syndrome" is a well recognized com-
plication of jejunoileal bypass surgery for obesity. This is
characterized by an influenza-like illness in 10–20% of
patients, with malaise, fever, non-erosive polyarthralgia
or arthritis and the development of skin lesions [1,2]. It
has been proposed that bacterial overgrowth in a blind
loop of bowel results in the formation of immune com-
plexes, which enter the circulation and produce the clini-
cal features [3-5]. The characteristic skin lesions appear in
crops as small erythematous macules (less than 1 cm
diameter) progressing through an indurated urticarial
stage to vesiculo-pustular lesions over a 24 – 48 hour
period, healing without scarring over about 2 weeks.
Lesions may recur every 4 – 6 weeks, and on the lower
limbs erythema nodosa-like nodules may be present [2,6].
The distribution classically favours the upper trunk and
extremities, and histology shows features of a neutrophilic
dermatosis, similar to Sweet's syndrome, with leukocyto-
clasis but no fibrinoid necrosis [2,6]. Joint symptoms are
described as episodic, migratory and polyarticular, with
involvement of the fingers and accompanying tenosyno-
vitis, but no long term damage or deformity [2].
A similar clinicopathological syndrome has been reported
rarely in patients with other bowel conditions such as
inflammatory bowel disease. In 1983, Jorizzo and associ-
ates [6] described four patients with an identical syn-
drome, who had not undergone jejunoileal bypass
surgery; however, each patient had gastrointestinal dis-
ease. Subsequently this syndrome has also been described
as a complication of inflammatory bowel disease in a fur-
ther 10 cases in the literature [7-10]. The term 'bowel asso-
ciated dermatosis-arthritis syndrome' has therefore been
proposed to include patients without bowel bypass sur-
gery for obesity. However, all of the published cases
shared the risk factor of bowel stasis to promote bacterial
overgrowth, with either disease or surgically induced
blind loops.
Bowel associated dermatosis-arthritis syndrome should
be distinguished from Henoch-Schonlein purpura (HSP)
which, whilst typically a disease of childhood, can affect
adults. The distinguishing features of HSP are the lack of
association with pre-existing bowel disease, the presence
of glomerulonephritis, and the immunoglobulin A (IgA)
deposition in the skin, glomeruli and gastrointestinal
mucosa [11]. The pathogenic mechanisms underlying
HSP are poorly understood, and whilst they may include
gut infection, other mucosal mechanisms such as drugs or
hypersensitivity have been postulated to lead to abnor-
malities in IgA synthesis [12].
Dermatological manifestations of Crohn's disease include
erythema nodosum, pyoderma gangrenosum and more
rarely a cutaneous granulomatous vasculitis. The latter
usually affects the distal lower limbs in association with
asymmetric large joint arthritis, fever abdominal pain and
diarrhoea [13]. This is distinguished from the bowel-asso-
ciated Dermatosis-Arthritis syndrome in which skin his-
tology has not been reported as showing granulomas and
where the distribution of rash favours the upper limbs and
joint disease includes small joints [14].
Other than steroids, various antibiotics including tetracy-
cline, minocycline, sulphapyridine, erythromycin and
metronidazole have been reported to suppress symptoms
in the Bowel Associated Dermatosis-Arthritis Syndrome,
although the response to these antibiotics has been incon-
sistent [2,15]. Restoration of normal bowel anatomy has
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also been curative though in many cases the syndrome is
self limiting [2].
Conclusion
We report a case of bowel associated dermatosis-arthritis
syndrome in a patient with complicated Crohn's disease,
a long standing ileo-rectal fistula and the recent creation
of a defunctioning ileostomy. Our patient responded
promptly to the administration of corticosteroids and
maintained remission for 3 years, similar to previous
reports in the literature. Although cutaneous leukocyto-
clastic vasculitis is a non specific manifestation of a wide
variety of pathologic processes [16] the other features of
this syndrome taken together (systemic upset, abdominal
pain, and the distribution of arthritis and skin lesions) are
diagnostic, and their recognition may prevent the need to
undertake exhaustive investigations.
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